Loading…
Picard Medical, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▼ -98.0% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| BIVIBiovie Inc | $2.16 | — | 1.6x | — | -150.76% | $18.25M |
| LPCNLipocine Inc. | $2.17 | — | 0.8x | — | -60.94% | $17.89M |
| NCELNewcelX Ltd. | $3.19 | — | 2.1x | — | — | $18.43M |
| TPSTTempest Therapeutics, Inc. | $1.06 | — |
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
Company description provided by Yahoo Finance.
| 18.6x |
| — |
| -931.14% |
| $17.53M |
| PTNPalatin Technologies Inc | $10.48 | 95.3x | 1.8x | — | -297.24% | $18.65M |
| KTTAPasithea Therapeutics Corp. | $0.56 | — | 0.4x | — | -65.49% | $18.71M |